Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Cash from Operations (2022 - 2023)

Historic Cash from Operations for Therapeutics (LENZ) over the last 2 years, with Q4 2023 value amounting to -$21.0 million.

  • Therapeutics' Cash from Operations rose 650.5% to -$21.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$60.4 million, marking a year-over-year increase of 3137.08%. This contributed to the annual value of -$59.4 million for FY2024, which is 163.8% up from last year.
  • Latest data reveals that Therapeutics reported Cash from Operations of -$21.0 million as of Q4 2023, which was up 650.5% from -$13.1 million recorded in Q3 2023.
  • Therapeutics' Cash from Operations' 5-year high stood at -$12.8 million during Q1 2023, with a 5-year trough of -$22.4 million in Q4 2022.